GlaxoSmithKline (GSK) pharmaceutical company sells all its shares in the Indian branch of food group Unilever. That is expected to generate a book profit of £ 2.9 billion (3.3 billion euros). GSK previously acquired a nearly 6 percent stake in the company as part of an earlier transaction completed this month. In December 2018, Unilever said it would acquire health food drink brands GSK in India and Bangladesh and other markets for EUR 3.3 billion in cash and shares in Hindustan Unilever. GSK marketed 133.8 million shares of Hindustan Unilever. The revenues were higher than previously accounted for.